We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toDossier-Conformance-and-Compliance-in-a-Rapidly-Changing-Global-Environment

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Can I Implement That Now? Efficiently Managing Post-Approval CMC Changes

    Session Chair(s)
      Leonard  Lescosky, JD, MS

      Leonard Lescosky, JD, MS

      • Vice President, CMC Regulatory Affairs
      • AbbVie, Inc., United States
    This interactive discussion will take on the complex problem of managing global post-approval CMC changes. Countries and regions have specific timelines for review an approval of changes, and it's not just approval we need, it's approval in the right order to make implementation of the change worthwhile.
    Learning Objective : Learn how to ensure that your manufacturing facility and regulatory affairs department are aligned with respect to the quality module of your products' dossiers.
      Peter  Lassoff, PharmD

      Compliance and Change Control: Checking that the Manufacture/CMC is Maintained in Accord with the Terms of the License

      Peter Lassoff, PharmD

      • Vice President and Head, Global Regulatory Affairs
      • IQVIA, United Kingdom
      Pascha  Clark-Higgs, RAC

      Changing Landscape of Managing CMC Post-Approval Changes: Challenges Now and How Global Regulations Impacts Us Going Forward

      Pascha Clark-Higgs, RAC

      • Associate Director, Regulatory Development Solutions, CMC
      • PPD, United States
      J. Mark  Wiggins, MS

      Pharmacopoeia Harmonization and Global Compendial Compliance

      J. Mark Wiggins, MS

      • Director, Compendial Compliance and Advocacy
      • Merck & Co., Inc., United States